Types of Cancer We Treat

Bladder Cancer

As leaders in the development of the most sophisticated treatments for people with bladder cancer, we have one of the largest bladder cancer clinical trials program in the United States. Our doctors are leading innovative clinical trials to treat noninvasive bladder cancer—the most common type. Our team of urologic surgeons, medical oncologists, radiation oncologists, imaging specialists, and urologic pathologists collaborates to diagnose and treat people who have bladder cancer.

Our research studies give you access to the newest approaches to care, including the latest diagnostic imaging techniques, such as PET/MRI scans, and advanced treatments, including immunotherapy, and blue light cystoscopy to detect and remove early stage bladder cancer. We are also at the forefront of surgical treatment of bladder cancer, including robotic-assisted surgery, bladder reconstructive surgery, and nerve-sparing techniques that help preserve urinary and sexual function.

Find a Doctor & Schedule
Diagnosis
Transurethral Resection
Intravesical Therapy
Surgery
Chemotherapy & Immunotherapy
Radiation Therapy

Related News

Popular YouTube Videos Mislead on Bladder & Prostate Cancer
Read Story
Perlmutter Cancer Center Expands Clinical Trials Portfolio
Read Story
Risk of Inadequate Bladder Cancer Therapy in Older Patients
Read Story
How Immunotherapy Is Changing Treatment for Bladder Cancer
Read Story
Frequently Asked Questions About COVID-19 & Bladder Cancer
Read Story
FDA Approves Treatment for a Common Type of Bladder Cancer
Read Story
Urologic Cancer Expert Brings Latest Science to Brooklyn
Read Story
NYU Langone Bladder Cancer Surgeon Advances Treatments
Read Story
Gary Steinberg, MD, to Lead Urology Bladder Cancer Program
Read Story
Surgical Oncologists Collaborate to Save a Patient’s Life
Read Story
After Testing, Novel Bladder Cancer Treatments Win Approval
Read Story
Research Yields New Treatments for Advanced Bladder Cancer
Read Story

Clinical Trials and Research Studies

Phase 2

Site for 10144 - A Phase II Study of Olaparib (AZD2281) in Patients with Metastatic/Advanced Urothelial Carcinoma with DNA-Repair Defects

Learn More

Phase 3

An open-label randomized controlled phase 3 study of enfortumab vedotin in combination with pembrolizumab with or without chemotherapy versus chemotherapy alone in previously untreated locally advanced or metastatic urothelial cancer

Learn More

Phase 3

A Phase 3 Randomized Open-Label Three Arm Study of PF-06801591 in Combination with BCG (Induction With or Without Maintenance) Versus BCG (Induction and Maintenance) in Participants with HR BCG-Na ve NMIBC (B8011006)

Learn More

Phase 3

A Phase 3 Randomized Comparator-controlled Study of the Efficacy and Safety of Pembro in Comb. with BCG in Participants with HR Non-muscle Invasive Bladder Cancer (HR NMIBC) that is Persistent or Recurrent Following BCG Induction

Learn More
View All Related Clinical Trials (19)